GlassScriptPhysician profile
Mandy J Morford
NPI 1245224484
$578.31
in general payments reported to CMS, 2019-2025
20 companies · $24.93 in 2025
The $24.93 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $276 · 2020: $47.54 · 2022: $73.91 · 2023: $132 · 2024: $24.27 · 2025: $24.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $180.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $84.90 | 2023 | Prolaris |
| Astrazeneca Pharmaceuticals LP | $58.09 | 2019-2020 | |
| Astellas Pharma US INC | $50.01 | 2022-2023 | Myrbetriq |
| Grifols USA, LLC | $38.74 | 2019 | |
| Sanofi-Aventis U.S. LLC | $36.54 | 2019 | |
| Sanofi Pasteur INC. | $34.64 | 2019 | |
| Merck Sharp & Dohme LLC | $30.00 | 2019-2020 | |
| Pfizer INC. | $28.52 | 2019 | |
| Hologic Sales and Service, LLC | $24.93 | 2025 | Thinprep 2000 Processor, Aptima |
| Teleflex LLC | $24.58 | 2022 | |
| Insulet Corporation | $24.27 | 2024 | Omnipod |
| Novartis Pharmaceuticals Corporation | $22.82 | 2019 | |
| Mallinckrodt Hospital Products INC. | $21.55 | 2020 | |
| Boston Scientific Corporation | $18.42 | 2023 | Rezum Generator |
| Abbvie INC. | $15.82 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $14.94 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $13.10 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.61 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $12.06 | 2019 | |
| Axonics, INC. | $11.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mandy Morford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.